Khan MS, Anker SD, Filippatos G, Ferreira JP, et al. Vascular Disease Burden, Outcomes, and Benefit with Empagliflozin in Heart Failure: Insights from the EMPEROR-Reduced Trial. J Card Fail 2023 Aug 7:S1071-9164(23)00275.
PMID: 37558088